As AbbVie and Soliton shake hands on a $550M merger, the FTC says 'not so fast'

As AbbVie and Soliton shake hands on a $550M merger, the FTC says 'not so fast'

Source: 
Endpoints
snippet: 

Back in May, AbbVie’s Allergan Aesthetics unit signed away $550 million in cash to scoop up drugmaker Soliton and its body sculpting device Resonic. Now, the FTC is requesting a bit more time to review the proposed merger.